SI-BONE Files 8-K on Operations & Financial Condition
Ticker: SIBN · Form: 8-K · Filed: 2024-01-08T00:00:00.000Z
Sentiment: neutral
Topics: financial-condition, regulation-fd, corporate-update
TL;DR
**SI-BONE just dropped an 8-K on its financials, signaling an update on company performance.**
AI Summary
SI-BONE, Inc. filed an 8-K on January 8, 2024, to report on its results of operations and financial condition, as well as to make a Regulation FD disclosure. This filing indicates that the company is providing an update on its financial performance, which is crucial for investors to understand the company's current health and future prospects. For shareholders or potential buyers, this matters because it offers a timely glimpse into the company's operational efficiency and financial stability, influencing investment decisions.
Why It Matters
This filing provides an early look at SI-BONE's financial health, which can impact investor confidence and stock valuation. It's essential for understanding the company's performance trends.
Risk Assessment
Risk Level: low — This 8-K is a routine disclosure of financial information and does not inherently present new risks, but rather provides data for risk assessment.
Analyst Insight
Investors should review the full details of the 'Results of Operations and Financial Condition' and 'Regulation FD Disclosure' once available to understand the specific financial updates and their potential impact on SI-BONE's stock.
Key Players & Entities
- SI-BONE, Inc. (company) — the registrant filing the 8-K
- January 8, 2024 (date) — date of earliest event reported and filing date
- 001-38701 (string) — Commission File Number for SI-BONE, Inc.
- Delaware (string) — State of incorporation for SI-BONE, Inc.
- 471 El Camino Real, Suite 101, Santa Clara, CA 95050 (string) — Address of principal executive offices for SI-BONE, Inc.
FAQ
What is the purpose of SI-BONE, Inc.'s 8-K filing dated January 8, 2024?
The 8-K filing by SI-BONE, Inc. on January 8, 2024, is primarily for reporting on the 'Results of Operations and Financial Condition' and for 'Regulation FD Disclosure', as stated in the 'ITEM INFORMATION' section of the filing.
What is SI-BONE, Inc.'s Commission File Number?
SI-BONE, Inc.'s Commission File Number is 001-38701, as indicated in the filing under the 'Commission File Number' section.
Where are SI-BONE, Inc.'s principal executive offices located?
The principal executive offices of SI-BONE, Inc. are located at 471 El Camino Real, Suite 101, Santa Clara, CA 95050, according to the 'BUSINESS ADDRESS' section of the filing.
What is the state of incorporation for SI-BONE, Inc.?
SI-BONE, Inc. is incorporated in Delaware, as specified in the filing under 'State or other jurisdiction of incorporation or organization'.
What is the business phone number for SI-BONE, Inc.?
The business phone number for SI-BONE, Inc. is (408) 207-0700, as listed in the 'BUSINESS PHONE' section of the filing.
Filing Stats: 605 words · 2 min read · ~2 pages · Grade level 9.7 · Accepted 2024-01-08 08:31:37
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share SIBN The Nasdaq Global Market
Filing Documents
- sibn-20240108.htm (8-K) — 32KB
- exhibit991_sibn12312023pre.htm (EX-99.1) — 11KB
- si-bonecorporateoverview.htm (EX-99.2) — 28KB
- si-bonecorporateoverview001.jpg (GRAPHIC) — 69KB
- si-bonecorporateoverview002.jpg (GRAPHIC) — 205KB
- si-bonecorporateoverview003.jpg (GRAPHIC) — 85KB
- si-bonecorporateoverview004.jpg (GRAPHIC) — 102KB
- si-bonecorporateoverview005.jpg (GRAPHIC) — 86KB
- si-bonecorporateoverview006.jpg (GRAPHIC) — 80KB
- si-bonecorporateoverview007.jpg (GRAPHIC) — 80KB
- si-bonecorporateoverview008.jpg (GRAPHIC) — 97KB
- si-bonecorporateoverview009.jpg (GRAPHIC) — 74KB
- si-bonecorporateoverview010.jpg (GRAPHIC) — 115KB
- si-bonecorporateoverview011.jpg (GRAPHIC) — 106KB
- si-bonecorporateoverview012.jpg (GRAPHIC) — 95KB
- si-bonecorporateoverview013.jpg (GRAPHIC) — 118KB
- si-bonecorporateoverview014.jpg (GRAPHIC) — 128KB
- si-bonecorporateoverview015.jpg (GRAPHIC) — 91KB
- si-bonecorporateoverview016.jpg (GRAPHIC) — 144KB
- si-bonecorporateoverview017.jpg (GRAPHIC) — 116KB
- si-bonecorporateoverview018.jpg (GRAPHIC) — 120KB
- si-bonecorporateoverview019.jpg (GRAPHIC) — 128KB
- si-bonecorporateoverview020.jpg (GRAPHIC) — 109KB
- si-bonecorporateoverview021.jpg (GRAPHIC) — 97KB
- si-bonecorporateoverview022.jpg (GRAPHIC) — 168KB
- si-bonecorporateoverview023.jpg (GRAPHIC) — 173KB
- si-bonecorporateoverview024.jpg (GRAPHIC) — 105KB
- si-bonelogoa07.jpg (GRAPHIC) — 31KB
- 0001459839-24-000003.txt ( ) — 3956KB
- sibn-20240108.xsd (EX-101.SCH) — 2KB
- sibn-20240108_lab.xml (EX-101.LAB) — 24KB
- sibn-20240108_pre.xml (EX-101.PRE) — 13KB
- sibn-20240108_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On January 8, 2024 , SI-BO NE, Inc. (the "Company") issued a press release (the "Press Release") announcing preliminary unaudited revenue for the fourth quarter and full year 2023. A copy of the Press Release is attached as Exhibit 99.1 to this current report on Form 8-K and is incorporated by reference herein.
01 – Regulation FD Disclosure
Item 7.01 – Regulation FD Disclosure. Members of the Company's management team expect to meet with investors and analysts the week of January 8, 2024, to discuss the Company performance, using presentation materials which are furnished and attached as Exhibit 99.2.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release dated January 8, 2024 99.2 Presentation dated January 2024 104 Cover Page Interactive Date File (embedded within the Inline XBRL document) The information in Items 2.02 and 7.01 and Exhibits 99.1 and 99.2, of this Current Report on Form 8-K are being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 as amended (Exchange Act), or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (Securities Act). The information in Items 2.02 and 7.01, and Exhibits 99.1 and 99.2 shall not be deemed incorporated by reference in any filing under the Securities Act, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SI-BONE, INC. Date: January 8, 2024 By: /s/ Anshul Maheshwari Anshul Maheshwari Chief Financial Officer (Principal Financial and Accounting Officer)